Two-Way Crossover Phase 1 Bioequivalence and Safety Studies in Healthy Adults for a Ready-to-Use, Room-Temperature, Liquid-Stable Glucagon Administered by Autoinjector, Prefilled Syringe, or Vial and Syringe.

M Khaled Junaidi,Matthew R Krecic,Nicole C Close,Valentina Conoscenti

Journal of diabetes science and technology（2023）

引用 0|浏览0

暂无评分

摘要

Bioequivalence and safety were established after 1 mg of this ready-to-use room-temperature liquid-stable glucagon, administered SC to healthy adults, by autoinjector, prefilled syringe, or vial and syringe kit.

查看译文

关键词

glucagon, glucagon autoinjector, glucagon bioequivalence, glucagon prefilled syringe, hypoglycemia, ready-to-use glucagon

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要